Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $775.0000 (-10.4%) ($650.0000 - $850.0000) on Tue. Jul. 14, 2009. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.48% (three month average) | RSI | 80 | Latest Price | $775.0000(-10.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 38.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -5.74% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.74% (StdDev 11.48%) | Hourly BBV | 0 () | Intraday Trend | -8.8% | | | |
|
5 Day Moving Average | $788(-1.65%) | 10 Day Moving Average | $654.99(18.32%) | 20 Day Moving Average | $539.6(43.62%) | To recent high | -20.5% | To recent low | 369.6% | Market Cap | $15.266b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |